DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 129 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,958,709 | -56.3% | 352,512 | -51.7% | 0.00% | -66.7% |
Q1 2024 | $9,066,584 | -25.6% | 730,587 | -16.2% | 0.00% | -25.0% |
Q4 2023 | $12,184,396 | -58.2% | 871,559 | -55.8% | 0.00% | -60.0% |
Q3 2023 | $29,153,853 | +130.1% | 1,973,856 | +101.3% | 0.01% | +150.0% |
Q2 2023 | $12,669,003 | +253991.5% | 980,573 | +92.9% | 0.00% | +100.0% |
Q1 2023 | $4,986 | -49.8% | 508,242 | -45.6% | 0.00% | -50.0% |
Q4 2022 | $9,935 | -99.9% | 933,787 | -34.4% | 0.00% | -33.3% |
Q3 2022 | $14,858,000 | -17.9% | 1,423,233 | -1.0% | 0.01% | -14.3% |
Q2 2022 | $18,106,000 | +19.2% | 1,438,176 | +8.0% | 0.01% | +40.0% |
Q1 2022 | $15,190,000 | -21.3% | 1,331,300 | -3.0% | 0.01% | -16.7% |
Q4 2021 | $19,311,000 | -3.2% | 1,372,501 | +32.2% | 0.01% | 0.0% |
Q3 2021 | $19,948,000 | +180.8% | 1,038,451 | +44.0% | 0.01% | +200.0% |
Q2 2021 | $7,103,000 | +53.3% | 721,046 | +53.0% | 0.00% | +100.0% |
Q1 2021 | $4,632,000 | +163.5% | 471,179 | +19.2% | 0.00% | 0.0% |
Q4 2020 | $1,758,000 | +5.3% | 395,192 | +2.3% | 0.00% | 0.0% |
Q3 2020 | $1,669,000 | -45.5% | 386,253 | +11.8% | 0.00% | 0.0% |
Q2 2020 | $3,065,000 | +196.7% | 345,540 | +18.1% | 0.00% | 0.0% |
Q1 2020 | $1,033,000 | -37.7% | 292,587 | +0.8% | 0.00% | 0.0% |
Q4 2019 | $1,659,000 | +54.8% | 290,189 | -3.2% | 0.00% | – |
Q3 2019 | $1,072,000 | +10.6% | 299,855 | +23.5% | 0.00% | – |
Q2 2019 | $969,000 | – | 242,884 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |